Thomas Moyer speaks on warfarin’s sensitive genotype test

289

Thomas Moyer, Mayo Clinic, Department of Laboratory Medicine and Pathology, describes the four basic categories of patients as identified through a sensitive genotype test, and how the doses of the blood-thinner warfarin would typically be adjusted to reflect differences in patients’ metabolism of warfarin and also their sensitivity, to prevent stroke or hospitalisation due to excessive bleeding.